Case | HBS Case Collection | 2008 (Revised from original 2007 version)
by Sunil Gupta and Das Narayandas
Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India.
Keywords: Price; Health Care and Treatment; Marketing Strategy; Product Launch; Planning; Biotechnology Industry; Pharmaceutical Industry; India;
Citation:
Gupta, Sunil, and Das Narayandas. "Biocon: Launching a New Cancer Drug in India." Harvard Business School Case 508-026, November 2008. (Revised from original August 2007 version.)
View Profile »View Publications »
Case | HBS Case Collection | 2013
Innovation at the Boston Consulting Group
Robert G. Eccles, Das Narayandas and Penelope Rossano
Keywords: innovation; strategy consulting; professional service firm; knowledge management; client management; product development; leadership; Customer Focus and Relationships; Customer Value and Value Chain; Independent Innovation and Invention; Innovation and Management; Innovation Leadership; Innovation Strategy; Value Creation; Consulting Industry;
Ron Johnson: Retail at Target, Apple, and J.C. Penney
Das Narayandas, Kerry Herman and Lisa Mazzanti
Eureka Forbes Ltd.: Managing the Selling Effort (A) (Photonovel Version)
Das Narayandas, Kallol Das and Kerry Herman